What is the recommended follow-up schedule after a follicular unit extraction (FUE) hair transplant?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

FUE Hair Transplant Follow-Up Timeline

Based on current evidence, follow-up after FUE hair transplantation should occur at: 2-3 days post-op, 1 week, 1 month, 2-3 months, 6 months, and 12 months, with the most critical monitoring periods being the first week for complications and 6-12 months for final graft survival assessment.

Immediate Post-Operative Period (First Week)

The first week is critical for identifying complications:

  • Days 2-3: First assessment for early complications 1, 2, 3

    • Monitor for forehead swelling (occurs in ~70% of patients) 1
    • Check for early signs of recipient-site necrosis (dusky discoloration can appear as early as day 2) 2
    • Assess for infection risk, particularly in high-risk patients (smokers, prolonged procedures >8 hours, dense packing >45 grafts/cm²) 2
    • Begin scab management with keratolytic shampoo at 48-72 hours post-op 3
  • Day 7 (1 week): Standard first follow-up 1, 4, 5

    • Evaluate wound healing and graft stability
    • Document any folliculitis (overall incidence ~12%) 6
    • Assess donor and recipient area erythema, perifollicular crusts 4
    • Check for dystrophic hairs and early complications 4

Early Follow-Up Phase (Weeks 2-8)

  • Weekly visits from weeks 1-8 are recommended for optimal monitoring 4
    • Track perifollicular erythema, white circles, perifollicular whitish halos 4
    • Monitor for folliculitis development (risk factors: summer surgery, >4000 grafts, density >45 grafts/cm², delayed first nursing >3 days) 6
    • Document repilation patterns and black dots 4

Intermediate Assessment (Months 2-6)

  • 1 month: Standard checkpoint 1

    • Assess temporary hair fall (occurs in ~43% of patients) 1
    • Evaluate healing progression
  • 2-6 months: Critical growth assessment period 1

    • Monitor hair regrowth patterns
    • Identify any delayed complications
    • This is when temporary shedding typically resolves

Final Outcome Assessment

  • 12 months (1 year): Definitive results evaluation 1, 5
    • Assess final graft survival rate (typically 85% in scarring alopecia, higher in non-scarring) 5
    • Document patient satisfaction (expect ~86% excellent results, ~12% satisfactory) 1
    • Evaluate final hair density and coverage

Common Pitfalls to Avoid

High-risk patients require more intensive monitoring:

  • Heavy smokers with prolonged procedures (>9 hours) need closer surveillance for necrosis 2
  • Summer procedures, high graft counts (>4000), and dense packing (>45 grafts/cm²) increase folliculitis risk—consider prophylactic measures 6
  • First nursing visit should occur within 3 days to reduce folliculitis risk 6

Critical warning signs requiring immediate attention:

  • Dusky discoloration appearing day 2-10 (potential necrosis) 2
  • Yellowish crusting with progressive necrosis (suggests secondary infection, particularly Pseudomonas aeruginosa) 2
  • Persistent or worsening folliculitis beyond expected timeframes 6

Adjunctive Therapy Considerations

While the evidence provided focuses primarily on PRP/PRF protocols for androgenetic alopecia rather than FUE-specific follow-up, if PRF is used as an adjunct to FUE, the protocol involves injections at month 0, month 1, and month 3 post-transplantation 7. Follow-up assessments for PRF-augmented procedures should occur at 1,2, and 6 months to evaluate enhanced graft survival 7.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.